Mark LeGolvan
Impact in
-
- Flame retardant materials and properties
- Synthesis and properties of polymers
Papers in
- Oncology 6
- Colorectal Cancer Treatments and Studies 3
-
- Genetic factors in colorectal cancer 3
- Co-authors
- Alexander K. Andrianov (2 shared papers)Murray B. Resnick (3 shared papers)Jianping Chen (1 shared paper)Ross Taliano (2 shared papers)Harold J. Wanebo (1 shared paper)Sukamal Saha (1 shared paper)N. E. Kemeny (1 shared paper)Markus Zuber (1 shared paper)
- Journals
- Human Pathology (2 papers)The Pediatric Infectious Disease Journal (1 paper)Macromolecules (1 paper)Journal of Surgical Oncology (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Mark LeGolvan
14 papers receiving 322 citations
Peers
Comparison fields: 5 of 78
- Polymers and Plastics 88
- Microbiology 4
- Biomaterials 51
- Immunology 66
- Hepatology 24
Countries citing papers authored by Mark LeGolvan
This map shows the geographic impact of Mark LeGolvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark LeGolvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark LeGolvan more than expected).
Fields of papers citing papers by Mark LeGolvan
This network shows the impact of papers produced by Mark LeGolvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark LeGolvan. The network helps show where Mark LeGolvan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark LeGolvan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 92 | |
| 2 | 2003 | 71 | |
| 3 | 2012 | 40 | |
| 4 | 2010 | 36 | |
| 5 | 2011 | 25 | |
| 6 | 2012 | 21 | |
| 7 | 2012 | 18 | |
| 8 | 2018 | 13 | |
| 9 | 2007 | 12 | |
| 10 | 2010 | 7 | |
| 11 | Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapy. | 2014 | 4 |
| 12 | 2011 | 3 | |
| 13 | 2020 | 1 | |
| 14 | 2018 | 1 |
About Mark LeGolvan
Mark LeGolvan is a scholar working on Oncology, Pathology and Forensic Medicine, Surgery, Immunology and Epidemiology, having authored 14 papers that have together received 344 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (3 papers), Genetic factors in colorectal cancer (3 papers), Flame retardant materials and properties (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Colorectal and Anal Carcinomas (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Polymers and Plastics (88 citations), Microbiology (4 citations), Biomaterials (51 citations), Immunology (66 citations) and Hepatology (24 citations). Mark LeGolvan has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Alexander K. Andrianov, Murray B. Resnick, Jianping Chen, Ross Taliano, Harold J. Wanebo, Sukamal Saha, N. E. Kemeny, Markus Zuber, Alfred Ayala and Chun‐Shiang Chung. Their work appears in journals such as Human Pathology, The Pediatric Infectious Disease Journal, Macromolecules, Journal of Surgical Oncology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.